Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
High-molecular-weight aggregates in repackaged bevacizumab
Malik Y. Kahook
, Lu Liu
,
Philip Ruzycki
, Naresh Mandava
, John F. Carpenter
, J. Mark Petrash
, David A. Ammar
Department of Ophthalmology and Visual Sciences
Institute of Clinical and Translational Sciences (ICTS)
Research output
:
Contribution to journal
›
Article
›
peer-review
123
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'High-molecular-weight aggregates in repackaged bevacizumab'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Syrinx
100%
Bevacizumab
100%
High Molecular Weight
100%
Compounding Pharmacy
100%
Intraocular Pressure
66%
Enzyme-linked Immunosorbent Assay (ELISA)
66%
Particulate Matter
66%
Polyacrylamide Gel Electrophoresis
66%
Micron-sized
66%
IgG Concentration
66%
Micro-flow Imaging
66%
Heavy Chain
33%
Size Exclusion Chromatography
33%
Protein Aggregates
33%
Ranibizumab
33%
Light Chain
33%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
33%
Ocular Neovascular Disease
33%
Aqueous Outflow
33%
Particulate Material
33%
Immunoglobulin IgG
33%
Medicine and Dentistry
Bevacizumab
100%
Intraocular Pressure
66%
Enzyme Linked Immunosorbent Assay
66%
Polyacrylamide Gel Electrophoresis
66%
Atmospheric Aerosol
66%
Immunoglobulin
33%
Obstruction
33%
Ranibizumab
33%
Heavy Chain
33%
Protein Aggregate
33%
Light Chain
33%
Size-Exclusion Chromatography
33%
Endothelial Cell Growth Factor
33%
Aqueous Humor Outflow
33%
Diseases
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bevacizumab
100%
Polyacrylamide Gel Electrophoresis
66%
Enzyme-Linked Immunosorbent Assay
66%
Immunoglobulin
33%
Obstruction
33%
Protein Aggregate
33%
Ranibizumab
33%
Endothelial Cell Growth Factor
33%
Diseases
33%